BDX 241220 230.00P (BDX241220P230000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

BDX241220P230000

Watchlist

2.32
-3.22-58.12%

15min DelayClose Dec 20 16:00 ET

4.08High1.50Low

Intraday

5D
Daily

News

Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Kevin TraversDec 20 10:29 ET
Becton Dickinson & Co Insider Sold Shares Worth $633,811, According to a Recent SEC Filing
MT NewswiresDec 20 10:21 ET
Unusual Options Activity: SLB, Z and Others Attract Market Bets, SLB V/OI Ratio Reaches 375.0
Moomoo NewsDec 19 11:30 ET
Express News | BD Says CEO Pay Ratio for 2024 Was 396 to 1
ReutersDec 19 10:43 ET
Express News | BD Says CEO Thomas Polen's 2024 Total Compensation Was $17.3 Mln - SEC Filing
ReutersDec 19 10:42 ET
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Kevin TraversDec 18 16:16 ET

Comments

103208831

Apr 18 11:43

$Becton Dickinson & Co (BDX.US)$ GAME OVER stock.

Moomoo AI

Feb 29 06:14

Despite a dip in earnings, Becton Dickinson's high P/E ratio persists due to anticipated robust future growth, outpacing the broader market. Investors' confidence in the company's future earnings is high, indicating the share price is unlikely to drop significantly soon.

Earnings Tell The Story For Becton, Dickinson and Company (NYSE:BDX)

Alvinnnnnnngenius

Dec 7, 2023 05:54

Big news

$Becton Dickinson & Co (BDX.US)$ BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

Moomoo AI

Nov 21, 2023 05:52

Dr. Silverman's extensive experience and zeal for innovation, evidence generation, clinical development, medical safety, and compliance is predicted to boost BD's innovation pipeline and foster improved, personalized care.

Press Release: BD Names Dr. Ronald Silverman as Chief Medical Officer

Moomoo AI

Oct 10, 2023 11:30

Market sentiment towards Becton, Dickinson and Company shows no major shift in the past year. However, the rise in total shareholder return hints at a growing positivity.

Investing in Becton Dickinson (NYSE:BDX) a Year Ago Would Have Delivered You a 15% Gain